Clinical Evidence

Efficacy and Safety of a PTPD-12-Containing Cream

A randomized, split-face clinical trial demonstrated that a cream containing PTPD-12 significantly reduced melanin levels in facial hyperpigmentation. The study showed a mean change in melanin index from 216.93 to 194.69 after 8 weeks of treatment, indicating its effectiveness in managing pigmentary disorders. Read more.

Enhanced Efficacy of Post-Procedural Skin Care

A study assessed a novel neuropeptide serum, which includes dipeptides, following botulinum toxin injections. The serum showed significant improvement in various facial attributes, suggesting that dipeptides can enhance post-procedural skincare. Read more.

Beta-Alanine and Aquagenic Pruritus

While not directly related to dipeptides, this study highlights the role of amino acids in skin conditions, suggesting a broader relevance of peptide-based treatments in dermatology. Read more.